期刊
NATURE IMMUNOLOGY
卷 16, 期 8, 页码 802-809出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.3212
关键词
-
类别
资金
- Medical Research Council [MC_U117597139] Funding Source: Medline
- Novo Nordisk Fonden [NNF12OC0002082] Funding Source: researchfish
- The Francis Crick Institute [10206] Funding Source: researchfish
- MRC [MC_U117597139] Funding Source: UKRI
Type III interferons (IFNs) or IFN-lambda s regulate a similar set of genes as type I IFNs, but whereas type I IFNs act globally, IFN-lambda s primarily target mucosal epithelial cells and protect them against the frequent viral attacks that are typical for barrier tissues. IFN-lambda s thereby help to maintain healthy mucosal surfaces through immune protection, without the significant immune-related pathogenic risk associated with type I IFN responses. Type III IFNs also target the human liver, with dual effects: they induce an antiviral state in hepatocytes, but specific IFN-lambda 4 action impairs the clearance of hepatitis C virus and could influence inflammatory responses. This constitutes a paradox that has yet to be resolved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据